• BSE
  • NSE
Partner with US Open an Demat Account EIPO Portfolio Tracker Watsapp Play Store App Store

News Details

06/11/2025 16:09

ANG Lifesciences Ind - Board Meeting Intimation for Consideration And Approval Of Unaudited Standalone And Consolidated Finan

ANG Lifesciences India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2025 ,inter alia, to consider and approve Pursuant to the Regulation 29 of the SEBI (Listing Obligation and Disclosure Requirements) Regulation, 2015, It is hereby informed you that the meeting of the Board of Directors of the Company is scheduled to be held on Friday, 14th November, 2025 at 05:00 P.M. at the Registered Office of the Company situated at Darbara Complex, SCO-113, District Shopping Centre, B Block, Ranjit Avenue, Amritsar-143001, inter alia transact the following business:\r\n1. To consider and approve the Standalone and Consolidated Un-Audited Financial Results of the Company for the quarter and half year ended 30th September, 2025.\r\n2. Any other business that may be necessary with the permission of Chairman.\r\n